Acyclovir (Cyclivex)
Acyclovir
Pharmacare limited û woodmead
Registration
- Applicant
- Pharmacare limited û woodmead
- Registrations
- 1
Variants
| Product | Strength and form | Registration | Status | Schedule | Leaflets |
|---|---|---|---|---|---|
| Cyclivex 200 MG tablets EACH TABLET CONTAINS ACYCLOVIR 200 MG | 200 mgTablets | 28071528/20.2.8/0715 | Registered | Not determined | None |
Regulatory status
This product is still scheduled by law even when this site could not determine which tier it falls under. The label carries the S number in a square border; ask a pharmacist if you need to know its schedule.
Listings for this ingredient that could not be applied to this product
S4: Acyclovir
- except when intended for application to the lips in the early treatment of recurrent Herpes simplex virus infections. (S1)
Consolidated Schedules 06 July 2026, lines 5141 to 5142
S1: Acyclovir
- when intended for application to the lips in the early treatment of recurrent herpes simplex virus infections. (S4)
Consolidated Schedules 06 July 2026, lines 112 to 113
This is an informational summary of the Medicines and Related Substances Act 101 of 1965 and its 2017 General Regulations. It is not medical advice and not legal advice. Always check the medicine's label, which carries the schedule number inside a square border, or ask a pharmacist if you are unsure.
2-Amino-9-(2-hydroxyethoxymethyl)-1H-purin-6-one
Drag to rotate. Structure from PubChem CID 135398513.
SAHPRA documents
SAHPRA has not published a professional information or patient information leaflet for this product.